A prospective, single-center, randomized, double masked, sham controlled study to evaluate the safety, efficacy and tolerability of OTX-TI (sustained release travoprost) Intracameral Depot compared to topical travoprost in subjects with OA & OHT.

Administered By

Awarded By

Contributors

Start/End

  • February 17, 2017 - January 18, 2019